MA44025B1 - Pde9 inhibitors for the treatment of peripheral diseases - Google Patents

Pde9 inhibitors for the treatment of peripheral diseases

Info

Publication number
MA44025B1
MA44025B1 MA44025A MA44025A MA44025B1 MA 44025 B1 MA44025 B1 MA 44025B1 MA 44025 A MA44025 A MA 44025A MA 44025 A MA44025 A MA 44025A MA 44025 B1 MA44025 B1 MA 44025B1
Authority
MA
Morocco
Prior art keywords
treatment
pde9 inhibitors
peripheral diseases
pde9
inhibitors
Prior art date
Application number
MA44025A
Other languages
French (fr)
Other versions
MA44025A1 (en
Inventor
Niels Svenstrup
Anna I Parachikova
James Mcarthur
Original Assignee
H Lundbeck As
Imara Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As, Imara Inc filed Critical H Lundbeck As
Priority claimed from PCT/US2017/040160 external-priority patent/WO2018009424A1/en
Publication of MA44025A1 publication Critical patent/MA44025A1/en
Publication of MA44025B1 publication Critical patent/MA44025B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne des inhibiteurs de pde9, leur synthèse et leur utilisation pour le traitement de l'hyperplasie bénigne de la prostate, de la thalassémie bêta et de la drépanocytose.The present invention relates to pde9 inhibitors, their synthesis and their use for the treatment of benign prostatic hyperplasia, beta thalassemia and sickle cell anemia.

MA44025A 2016-07-06 2017-06-30 Pde9 inhibitors for the treatment of peripheral diseases MA44025B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662359080P 2016-07-06 2016-07-06
PCT/US2017/040160 WO2018009424A1 (en) 2016-07-06 2017-06-30 Pde9 inhibitors for treatment of peripheral diseases

Publications (2)

Publication Number Publication Date
MA44025A1 MA44025A1 (en) 2019-05-31
MA44025B1 true MA44025B1 (en) 2020-05-29

Family

ID=67262004

Family Applications (1)

Application Number Title Priority Date Filing Date
MA44025A MA44025B1 (en) 2016-07-06 2017-06-30 Pde9 inhibitors for the treatment of peripheral diseases

Country Status (1)

Country Link
MA (1) MA44025B1 (en)

Also Published As

Publication number Publication date
MA44025A1 (en) 2019-05-31

Similar Documents

Publication Publication Date Title
MX2022010638A (en) Pde9 inhibitors for treatment of peripheral diseases.
EA201891268A1 (en) COMPOUNDS WHICH CAN BE USED AS KINASE INHIBITORS
FR3021970B1 (en) ANTIBODY AGAINST GALECTIN 9 AND INHIBITOR OF THE SUPPRESSIVE ACTIVITY OF T REGULATORY LYMPHOCYTES
MX2023000191A (en) Methods of making and using pde9 inhibitors.
MA39211A1 (en) Tricyclic compounds as anti-cancer agents
MA35638B1 (en) 2-thiopyrimidinones
EA201290894A1 (en) AZETIDINE DERIVATIVES OF PIPERIDIN-4-ILA AS JAK1 INHIBITORS
MA39094A1 (en) Combination therapy comprising an inhibitor of mdm2 and one or more additional pharmaceutically active principles for the treatment of cancers
TN2017000507A1 (en) Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
MA38827A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in the treatment of hyperproliferative diseases
MA38284A1 (en) Inhibitors of 2,3-dihydroimidazol [1,2-c] pyrimidin-5 (1 h) -one-2-lipoprotein-associated phospholipase (lp-pla2)
MA47356A1 (en) Isochromene derivatives useful as inhibitors of phosphoinositide 3-kinases
MA44948A1 (en) Bace 1 inhibitors
MA47736B1 (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
MA38925B1 (en) Substituted phenylalanine derivatives
FR3084254B1 (en) LANIFIBRANOR DERIVATIVES
MA38253A1 (en) Compositions comprising vortioxetine and donepezil
MA39837B1 (en) Halogenated quinazolin-thf-amines as pde1 inhibitors
MA44025B1 (en) Pde9 inhibitors for the treatment of peripheral diseases
MA39230A1 (en) Hexahydrofuropyrroles used as inhibitors of pde1
MA44660B1 (en) (+) -AZASETRON FOR ITS USE IN THE TREATMENT OF EAR DISORDERS
MA39533B1 (en) Compounds, pharmaceutical composition and their use in the treatment of neurodegenerative diseases
MA41574B2 (en) Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases
MA51297B1 (en) Quinazolinones as parp14 inhibitors
MA45537B1 (en) 1h-pyrazolo [4,3-b] pyridines as pde1 inhibitors